Originally posted by the Voice of America.
Voice of America content is produced by the Voice of America,
a United States federal government-sponsored entity, and is in
the public domain.


Experts Warn of China's Emergency Use of COVID-19 Vaccine

John Xie

   China in recent months has been injecting hundreds of thousands of
   people with three preliminary coronavirus vaccianes that are being
   tested for safety and efficacy.

   While the world awaits a proven drug to fight the pandemic, at least
   three vaccine candidates have been given to front-line medical
   professionals, staff of state-owned companies, and government officials
   since July under an emergency use program approved by Beijing.

   China National Biotec Group (CNBG), a subsidiary of state-owned
   Sinopharm, has administered two experimental vaccine candidates to
   around 350,000 people outside its clinical trials, CNBG chairman Yang
   Xiaoming said recently. The company also donated 200,000 doses of one
   of the candidate vaccines that is still undergoing clinical trials in
   Wuhan, where the pandemic was first reported.

   Another drugmaker, Sinovac Biotech, has injected 90% of its employees
   and their family members, or about 3,000 people, Yin Weidong, the
   company's CEO, said this month.

   "At present, tens of thousands of people in Beijing should have been
   vaccinated with Sinovac's vaccine," Yin told Chinese state media.

   Separately, Beijing also gave approval in June for members of the armed
   forces to receive an experimental vaccine developed by CanSino
   Biologics, a biopharmaceutical company that is backed by the military.

.